Tag: Johnson & Johnson

We’re lifting our price target on Cardinal Health after issuing rosy profit guidance

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

AI stocks rebound, and why J&J’s earnings guidance cut is not cause for concern

Jim Cramer says Wall Street is fleeing the AI trade and buying these stocks instead

Here are 4 forces that drove a tough week for stocks

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

3 of our stocks rode the AI rally, while 3 others fell out of favor since last month

J&J falls despite a beat-and-raise quarter. Why we’re raising our price target anyways

Stock futures slip after U.S., Iran exchange airstrikes again: Live updates

Jim Cramer says these are the 5 stocks to buy during this market rotation